Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Lilly’s Baricitinib (Olumiant) to treat rheumatoid arthritis

europeanpharmaceuticalreviewJuly 05, 2017

Tag: NICE , Lilly , Baricitinib

PharmaSources Customer Service